---

Top Highlights for April 2013:  (Please click on news title to view details)

 

1. India's Shasun Pharma and Debiopharm Group™ enter into licensing agreement for the manufacturing and commercialization of brain drug
2. India's Agila forms a JV for Biosimilar with Pfenex, Inc
3. Sun Pharma, India among world's most 100 innovative companies (Forbes 2012) eyes USA skin market.
4. India's Ranbaxy and Daiichi promote generics in Brazil through hybrid model Daiichi Sankyo Brazil
5. India-based Spinchrom Life Sciences to market innovative BLItz Platform from Pall’s ForteBio Division (USA)
6. Genzyme signs deal with India's Society for Indian Academy of Medical Genetics (SIAMG) for genetic research
7. Singapore woos investments from Indian Pharma companies
8. Scotland keen on building beneficial partnership with Indian Lifesciences company
9. WHO approves Indian vaccine standards and making India the first country in 2012 to have passed the strict levels of seven indicators.